Just wanted to clarify that Generic OxyContin is GUARANTEED one of the two drugs with BE results being reported next quarter. Nasrat stated this on the CC's earlier this year AND it's in black and white in the most recent 10-K. It is scheduled to be filed in calendar year Q2 of next year.
Generic Concerta is also in the pipeline and has been for years and years now, but it's a 50/50 chance whether this is also one of the drugs with results being reported next quarter. Remember, this drug is the one we got back from SunGen. Elite now owns it 100%.
OxyContin Annual Sales
- "OxyContin generated $2.3 billion in net sales in 2010. “By 2018, that number had dropped over half to $820 million and by 2020 had further dropped to $517 million,” Purdue executives said in filings. OxyContin sales are expected to continue to drop in 2025 and in 2027 when patent protections expire and the product likely serious competition from generic entrants."
Concerta Annual Sales
- "According to IQVIA Health, the Concerta brand and generic products had US sales of around USD 1.159 billion for the most recent 12 months ending in June 2020."
----------------------------------------------------------------------------------------------------------------------------------------
News 
Market Data 
Discover 
AI
